Founding Partner
The U.S. Food and Drug Administration has classified the recall of certain Hamilton Medical coaxial breathing circuit sets as a Class I recall, the agency’s most serious recall classification. The affected breathing circuits are used with HAMILTON-C1, HAMILTON-T1, and HAMILTON-MR1 ventilators and are designed to connect the ventilator to a patient’s breathing tube or respiratory mask. A defect involving the expiratory valve can interfere with the patient’s ability to exhale properly, potentially causing inadequate ventilation, impaired gas exchange, and dangerously low blood oxygen levels. As of July 2, 2026, Hamilton Medical had reported four serious injuries associated with the problem and no deaths.
For a patient who already depends on mechanical ventilation because of serious illness, trauma, surgery, respiratory failure, or another medical condition, interruption of normal airflow can create an immediate medical emergency. A ventilator and its breathing circuit must consistently move respiratory gases in and out of the patient’s lungs. When an expiratory valve fails to open as intended, pressure can build, and the patient’s ability to eliminate exhaled gas can be compromised. The FDA warns that the resulting respiratory impairment may lead to oxygen desaturation, also known as hypoxemia.
Patients who suffered unexpected oxygen deprivation, respiratory deterioration, cardiac complications, neurological injuries, organ damage, prolonged hospitalization, or other injuries while connected to one of the affected Hamilton Medical breathing circuits may have questions about whether the recalled medical device contributed to what happened. Families of critically ill patients may also have difficulty discovering the cause because a ventilation complication can occur while a patient is sedated, unconscious, or unable to communicate.
A medical device injury investigation may therefore require much more than reviewing the patient’s final diagnosis. Medical records, ventilator logs, alarm histories, nursing records, respiratory therapy documentation, product numbers, lot numbers, hospital inventory records, and the actual breathing circuit may all become important evidence.
The FDA recall involves certain Hamilton Medical coaxial breathing circuit sets used with HAMILTON-C1, HAMILTON-T1, and HAMILTON-MR1 ventilators. These components create the pathway connecting the ventilator with the patient and therefore play a critical role in moving respiratory gases during mechanical ventilation.
The FDA identifies four affected product configurations:
| Product Name | Product Number | UDI-DI |
| T1 CIRCUIT 240 +VALVE B/10 | 260127 | 07630002802956 |
| T1 CIRCUIT 180 +VALVE B/20 | 260128 | 07630002802963 |
| MR1 CIRCUIT 300 +VALVE B/10 | 260167 | 07630002802970 |
| MR1 CIRCUIT 480 +VALVE B/8 | 260168 | 07630002802987 |
The FDA recall database identifies affected lot numbers running from 200379 through 205050, inclusive. However, hospitals and other healthcare facilities should use the current FDA and Hamilton Medical recall information when verifying inventory. The recall remains classified as Class I.
Identifying the exact product is important in a potential injury claim. Two breathing circuits may appear almost identical to a patient or family member, while only certain product numbers or lots are included in a particular recall. Hospitals ordinarily maintain supply-chain and inventory information that may help establish what equipment was used during treatment, even when the patient never personally saw the packaging.
For patients who suffered an unexplained respiratory emergency while receiving ventilation, determining whether a recalled circuit was involved may require obtaining records from the hospital, respiratory therapy department, biomedical engineering department, purchasing department, or medical device tracking system. The patient’s chart alone may not always identify every disposable component connected to a ventilator.
According to the FDA, certain affected breathing circuits were preassembled with expiratory valve sets that may not perform as intended. The problem involves the membrane inside the expiratory valve. In some affected units, that membrane can adhere to the sealing ring located on the valve body.
That adhesion can prevent the valve from opening properly and interfere with the flow of gas leaving the patient’s lungs. The FDA states that when the membrane is stuck to the sealing ring, the malfunction can appear within the first few breaths after ventilation begins.
This is significant because mechanical ventilation depends upon controlled inspiratory and expiratory phases. Supplying air or oxygen to a patient is only one part of mechanical ventilation. The patient must also be able to exhale adequately so that carbon dioxide and other respiratory gases can leave the lungs.
If the expiratory pathway becomes obstructed, end-expiratory pressure may become excessive or expiratory flow may become abnormally low. Hamilton ventilators are designed to respond by producing an “Exhalation Obstructed” alarm. An alarm, however, does not eliminate the underlying danger. Once the obstruction occurs, clinicians must recognize the situation, determine why it is occurring, and intervene quickly enough to prevent injury.
One particularly troubling aspect of the reported problem is that the defect may not necessarily be identified during a standard pre-operative ventilator test unless a test lung is actively ventilated. That means an affected component could appear acceptable during preparations but malfunction when actual ventilation begins.
Ventilators are commonly associated with helping a patient inhale, but effective exhalation is equally important. During normal breathing, oxygen enters the lungs, and carbon dioxide is removed. Mechanical ventilation must support that exchange while maintaining appropriate pressures inside the patient’s lungs.
When expiratory airflow is obstructed, the patient may be unable to release gas from the lungs normally. Pressure can accumulate, ventilation becomes ineffective, and gas exchange can deteriorate. The FDA specifically warns that obstruction may result in inadequate ventilation and oxygen desaturation.
Hypoxemia means the blood contains an abnormally low level of oxygen. Every organ depends upon oxygenated blood, but the brain and heart are particularly vulnerable when oxygen delivery becomes inadequate.
Depending on the severity and duration of the event, a patient may experience respiratory distress, declining oxygen saturation, changes in blood pressure, abnormal heart rhythms, loss of consciousness, cardiac arrest, neurological injury, or damage to other organs. Critically ill patients may have even less ability to tolerate an episode of impaired ventilation because their bodies are already under significant physiological stress.
Another danger is that the resulting symptoms may initially be attributed to the patient’s underlying disease rather than a device malfunction. A ventilated patient may already have pneumonia, acute respiratory distress syndrome, severe trauma, sepsis, neurological disease, or postoperative complications. When oxygen saturation suddenly drops, healthcare providers must evaluate numerous possible explanations.
That overlap can make medical device injury cases particularly complicated. Establishing what actually happened may require reconstructing the patient’s respiratory status immediately before, during, and after the suspected malfunction.
The FDA identifies a Class I medical device recall as the most serious category. In its current communication concerning the Hamilton Medical breathing circuit sets, the agency warns that continued use of affected devices may cause serious injury or death.
The classification does not mean every patient connected to an affected breathing circuit will suffer an injury. It means the defect’s potential consequences are sufficiently serious that continued use presents an unacceptable safety concern.
The FDA first issued an Early Alert regarding the device issue on June 8, 2026. On July 2, the agency updated its communication to state that it had classified the issue as a Class I recall. The FDA issued another update on August 11 to align its recommendations with Hamilton Medical’s latest customer notification.
The formal recall database states that Hamilton Medical initiated the recall on May 29, 2026. It identifies the FDA-determined cause as component design or selection and describes the concern as expiratory valve membranes sticking to the valve body, which can produce inadequate ventilation and oxygen desaturation.
For injured patients, these regulatory findings may become part of a broader investigation, but a recall by itself does not automatically establish that the product caused an individual patient’s injury. A lawsuit still generally requires evidence connecting the particular device and alleged defect to the injuries claimed.
As of July 2, 2026, Hamilton Medical had reported four serious injuries and no deaths associated with the breathing circuit issue, according to the FDA.
Reported injury numbers should not automatically be interpreted as the total number of people who may have experienced a malfunction or related complication. Medical device surveillance develops over time. Some events may not initially be recognized as device-related, while others may be reported later by hospitals, healthcare professionals, patients, manufacturers, or family members.
A patient may also experience an event that does not immediately look like a product malfunction. For example, a sudden decline in oxygen saturation may be attributed to the patient’s underlying respiratory condition, movement of the endotracheal tube, secretions, pulmonary complications, or another clinical cause.
The discovery of a recall may cause patients, families, and healthcare facilities to revisit previously unexplained incidents. If a patient’s oxygen level unexpectedly dropped immediately after a new breathing circuit was connected, an “Exhalation Obstructed” alarm occurred, and the patient’s condition improved after the circuit or valve was changed, those facts may warrant careful investigation.
A patient’s medical records can provide important clues. Respiratory therapy notes, ventilator alarm records, oxygen saturation trends, arterial blood gas results, nursing documentation, rapid response records, and records of device replacement can help establish the sequence of events.
The possible consequences depend on how severely ventilation was impaired, how long the obstruction lasted, the patient’s baseline health, and how quickly clinicians identified and corrected the problem.
Potential injuries or medical complications may include:
Not every complication occurring during ventilation is caused by a breathing circuit defect. Mechanical ventilation is frequently used in patients who are already severely ill. For that reason, causation becomes one of the central questions in a medical device lawsuit.
Attorneys investigating a claim may need to compare the patient’s condition before the suspected event with what occurred immediately afterward. Blood oxygen measurements, blood gas testing, imaging, neurological examinations, cardiac records, and other clinical evidence may help determine whether a sudden period of impaired ventilation caused or contributed to the patient’s injuries.
The FDA currently instructs customers not to use affected coaxial breathing circuit sets. Healthcare facilities are directed to inspect their inventories, identify affected item and lot numbers, quarantine those products, and return them to Hamilton Medical for replacement. Facilities are also expected to inform potential users of the problem and ensure that recommended actions are followed.
These instructions matter both for preventing future injuries and for evaluating incidents that may already have occurred.
Once a healthcare institution receives a safety communication involving a potentially dangerous medical device, questions may arise concerning when the notice was received, which departments received it, how quickly affected stock was identified, whether the information was distributed to respiratory therapists and other clinicians, and whether recalled products remained available for patient care.
Those issues can differ substantially from the question of whether the product itself was defective. Depending on the circumstances and applicable state law, a claim may involve a manufacturer, supplier, healthcare institution, or another party. Responsibility cannot be assumed simply from the existence of a recall.
A detailed investigation is necessary to determine which parties had duties related to the product and whether any failure contributed to a patient’s injury.
Patients and families dealing with serious medical injuries are often focused on immediate treatment rather than identifying the exact manufacturer of each device used during hospitalization. That is understandable. However, evidence concerning disposable medical devices can disappear quickly because breathing circuits may ordinarily be discarded after use.
If a recalled device may have been involved in a serious injury, preserving evidence can become critically important.
Patients or their families may want to obtain complete medical records, including respiratory therapy records and any documentation concerning ventilator alarms. The records should identify when ventilation began, when respiratory deterioration occurred, what alarms were observed, whether the circuit or expiratory valve was changed, and what happened after replacement.
Potentially useful evidence may include:
Patients should generally avoid disposing of medical devices, packaging, labels, or correspondence that could help identify an affected product if those items are in their possession.
A patient who proves that a defective medical device caused injuries may be entitled to pursue damages permitted under the law governing the case. The nature and amount of compensation depend on the severity of the injury and its long-term consequences.
Economic damages may include past medical expenses, future treatment costs, rehabilitation, medications, home healthcare, assistive equipment, lost income, and reduced future earning capacity.
Noneconomic damages may address physical pain, emotional suffering, disability, loss of independence, cognitive impairment, disfigurement, and diminished quality of life, subject to the law of the jurisdiction involved.
A severe hypoxic brain injury can generate extraordinary lifetime costs. A patient who survives profound oxygen deprivation may require rehabilitation, occupational therapy, physical therapy, speech therapy, nursing support, home modifications, mobility equipment, and lifelong assistance with daily activities.
When a medical device incident results in death, qualifying surviving family members or the estate may have wrongful death or survival claims under applicable state law. Those cases require separate analysis because each state determines who can bring the claim and what damages may be recovered.
Every state imposes deadlines for filing personal injury and wrongful death lawsuits. These statutes of limitation vary significantly, and additional rules may change the filing deadline depending upon the defendant, patient’s age, date the injury was discovered, or other circumstances.
Medical device litigation can involve additional complications because the incident may initially be treated as a medical event rather than a product malfunction. A family might learn of the recall weeks or months after an unexplained respiratory emergency.
Waiting for a regulatory investigation to conclude can create unnecessary risk if a legal deadline is already running. A recall does not ordinarily suspend every applicable statute of limitation.
The safest approach is to have the potential claim evaluated promptly enough to identify the governing deadlines and preserve available evidence.
Mechanical ventilation is frequently used when patients are at their most medically vulnerable. Patients and families have a right to expect that breathing circuits and other essential components will perform as intended. When a recalled medical device interferes with ventilation and a patient suffers oxygen deprivation, neurological damage, cardiac injury, organ damage, prolonged hospitalization, or another serious complication, determining what happened can require immediate investigation.
Parker Waichman LLP is a national personal injury law firm representing people harmed by dangerous and defective medical products. Our attorneys can investigate whether an affected Hamilton Medical coaxial breathing circuit was used, obtain relevant medical and product records, evaluate the circumstances surrounding a ventilation emergency, identify potentially responsible parties, and determine whether compensation may be available under applicable law.
Evidence associated with disposable medical equipment can disappear, and legal filing deadlines differ from state to state. Families should not assume that a hospital or manufacturer will preserve every record or component needed to establish what occurred.
If you or a loved one suffered a serious injury while receiving mechanical ventilation and you believe a recalled Hamilton Medical breathing circuit may have been involved, call Parker Waichman LLP at 1-800-YOUR-LAWYER (1-800-968-7529) for a free consultation. There is no charge to have your potential claim reviewed. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.
Parker Waichman LLP
Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
We handle mass torts cases nationwide. Please contact our office to learn more.